Research Article

Association of IFNAR2 rs2236757 and OAS3 rs10735079 Polymorphisms with Susceptibility to COVID-19 Infection and Severity in Palestine

Table 5

Association of IFNAR2 rs2236757 and OAS3 rs10735079 polymorphisms with COVID-19 signs and symptoms in all patients.

rs2236757 (IFNAR2)YesNo.OR (95% CI) value

Sore throatCodominant
GG1332ref0.011
GA23252.52 (1.02–6.24)
AA060.0 (0.0- NA)
Dominant
GG1332ref0.124
GA + AA23311.98 (0.82–4.76)
Recessive
GG + GA3657ref0.026
AA060.0 (0.0- NA)
Over dominant
GG + AA1338ref0.018
GA23252.89 (1.18–7.13)
Log additive
36631.25 (0.61–2.57)0.538

DyspneaCodominant
GG1629ref0.002
GA29204.28 (1.57–11.71)
AA60NA
Dominant
GG16290.001
GA + AA35204.81 (1.77–13.09)
Recessive
GG + GA4549ref0.054
AA60NA
Over dominant
GG + AA2229ref0.009
GA29203.49 (1.32–9.25)
Log additive
51494.70 (1.80–12.27)<0.001

rs10735079 (OAS3)YesNoOR (95% CI) value

Sore throatCodominant
GG1517ref0.004
GA17200.88 (0.33–2.38)
AA4260.16 (0.04–0.58)
Dominant
GG1517ref0.099
GA + AA21460.47 (0.19–1.16)
Recessive
GG + GA3237ref<0.001
AA4260.17 (0.05–0.55)
Over dominant
GG + AA1943ref0.162
GA17201.86 (0.78–4.45)
Log additive
36630.44 (0.24–0.79)0.004

Muscle achesCodominant
GG2210ref0.079
GA27111.11 (0.38–3.22)
AA14160.36 (0.12–1.09)
Dominant
GG2210ref0.394
GA + AA41270.67 (0.26–1.70)
Recessive
GG + GA4921ref0.0248
AA14160.34 (0.13–0.88)
Over dominant
GG + AA3626ref0.191
GA27111.81 (0.74–4.47)
Log additive
63370.60 (0.34–1.05)0.068

Best model to explain the association according to the Akaike information criterion. The odds ratios and the values were from logistic regression models adjusted for age, gender, smoking history, history of hypertension, diabetes mellitus, and coronary artery disease. After Bonferroni correction, a value <0.025 was considered significant. OR, odds ratio; ref, reference; NA, not applicable. values below the significance threshold are highlighted in bold